We are developing enhanced therapeutics for specific cancers and cancer supportive care, infectious diseases such as HIV, influenza and coronavirus, and central and peripheral nervous system disorders such as Alzheimer’s Disease, Multiple Sclerosis, Pain and Addiction. The status of our lead therapeutic products in development is shown in our product pipeline.